The days of pathologists examining tissue samples on glass slides under a microscope may be drawing to an end. New technology granted marketing rights on April 12 by the Food and Drug Administration enables the review and interpretation of digital surgical pathology slides prepared from biopsied tissue.
Philips Medical Systems received the FDA approval for its Philips IntelliSite Pathology Solution, or PIPS.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access